Cargando…
Endoplasmic reticulum stress in the development of multiple myeloma and drug resistance
Multiple myeloma (MM) is a haematological malignancy of mature antibody‐secreting plasma cells. Currently, MM is incurable, but advances in drug treatments have increased patient lifespan. One of the characteristics of MM is the excessive production of monoclonal immunoglobulin (also referred to as...
Autores principales: | Nikesitch, Nicholas, Lee, James M, Ling, Silvia, Roberts, Tara Laurine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822402/ https://www.ncbi.nlm.nih.gov/pubmed/29484184 http://dx.doi.org/10.1002/cti2.1007 |
Ejemplares similares
-
Molecular mechanisms in multiple myeloma drug resistance
por: Nikesitch, Nicholas, et al.
Publicado: (2016) -
Oxidative and endoplasmic reticulum stress in respiratory disease
por: Chen, Alice C‐H, et al.
Publicado: (2018) -
Endoplasmic reticulum and oxidative stress in immunopathology: understanding the crosstalk between cellular stress and inflammation
por: Hasnain, Sumaira Z
Publicado: (2018) -
Looking into Endoplasmic Reticulum Stress: The Key to Drug-Resistance of Multiple Myeloma?
por: Wang, Guangqi, et al.
Publicado: (2022) -
The Role of Chaperone-Mediated Autophagy in Bortezomib Resistant Multiple Myeloma
por: Nikesitch, Nicholas, et al.
Publicado: (2021)